Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report)’s share price gapped up prior to trading on Friday . The stock had previously closed at $0.73, but opened at $0.76. Elite Pharmaceuticals shares last traded at $0.72, with a volume of 176,436 shares changing hands.
Elite Pharmaceuticals Price Performance
The company has a quick ratio of 1.90, a current ratio of 3.27 and a debt-to-equity ratio of 0.12. The company has a 50 day moving average price of $0.55 and a 200-day moving average price of $0.51. The company has a market cap of $759.71 million, a price-to-earnings ratio of -35.56 and a beta of 0.17.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Featured Stories
- Five stocks we like better than Elite Pharmaceuticals
- Profitably Trade Stocks at 52-Week Highs
- Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making?
- Stock Average Calculator
- Value Alert: 3 High-Yield Stocks Trading at 52-Week Lows
- Health Care Stocks Explained: Why You Might Want to Invest
- Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
